Search filters

List of works by Hongtao Zhang

Challenges in the clinical utility of the serum test for HER2 ECD

scientific article published on April 3, 2012

Development of anti-EGF receptor peptidomimetics (AERP) as tumor imaging agent

scientific article published on February 15, 2011

Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function

scientific article published on September 24, 2010

IL8 and Cathepsin B as Melanoma Serum Biomarkers

scientific article published on February 25, 2011

Immune regulation by histone deacetylases: a focus on the alteration of FOXP3 activity

scientific article published on November 29, 2011

Inhibition of a naturally occurring EGFR oncoprotein by the p185neu ectodomain: implications for subdomain contributions to receptor assembly

scientific article published on March 5, 1998

Lysosome-dependent p300/FOXP3 degradation and limits Treg cell functions and enhances targeted therapy against cancers

scientific article published on 02 May 2013

Molecular and biological role of the FOXP3 N-terminal domain in immune regulation by T regulatory/suppressor cells

scientific article published on October 2, 2012

Monitoring serum HER2 levels in breast cancer patients

scientific article published on 22 May 2015

Progress of molecular targeted therapies for prostate cancers

scientific article published on November 29, 2011

Structural Features and PF4 Functions that Occur in Heparin-Induced Thrombocytopenia (HIT) Complicated by COVID-19

scientific article published on 10 October 2020

Structural Insights into the Down-regulation of Overexpressed p185 Protein of Transformed Cells by the Antibody chA21

scientific article published on June 16, 2011

Therapeutic monoclonal antibodies for the ErbB family of receptor tyrosine kinases

scientific article published on July 1, 2003

YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14

scientific article published on June 11, 2012

scFv-Based “Grababody” as a General Strategy to Improve Recruitment of Immune Effector Cells to Antibody-Targeted Tumors

scientific article published on February 8, 2013